RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Jiangsu Hengrui Pharmaceuticals Co - Stock

Jiangsu Hengrui Pharmaceuticals Co Debt 2024

Jiangsu Hengrui Pharmaceuticals Co Debt

-20,261.25 CNY

Ticker

600276.SS

ISIN

CNE0000014W7

WKN

A0M4DV

In 2024, Jiangsu Hengrui Pharmaceuticals Co's total debt was -20,261.25 CNY, a 52.31% change from the -13,302.75 CNY total debt recorded in the previous year.

Jiangsu Hengrui Pharmaceuticals Co Aktienanalyse

What does Jiangsu Hengrui Pharmaceuticals Co do?

Jiangsu Hengrui Pharmaceuticals Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Jiangsu Hengrui Pharmaceuticals Co's Debt Structure

Jiangsu Hengrui Pharmaceuticals Co's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Jiangsu Hengrui Pharmaceuticals Co's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Jiangsu Hengrui Pharmaceuticals Co’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Jiangsu Hengrui Pharmaceuticals Co’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Jiangsu Hengrui Pharmaceuticals Co stock

What is the debt of Jiangsu Hengrui Pharmaceuticals Co this year?

Jiangsu Hengrui Pharmaceuticals Co has a debt level of -20,261.25 CNY this year.

What was the debt of Jiangsu Hengrui Pharmaceuticals Co compared to the previous year?

The debt of Jiangsu Hengrui Pharmaceuticals Co has increased by 52.31% compared to the previous year increased.

What are the consequences of high debt for investors in Jiangsu Hengrui Pharmaceuticals Co?

High debt can pose a risk for investors of Jiangsu Hengrui Pharmaceuticals Co, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Jiangsu Hengrui Pharmaceuticals Co?

Low debt means that Jiangsu Hengrui Pharmaceuticals Co has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Jiangsu Hengrui Pharmaceuticals Co affect the company?

An increase in debt of Jiangsu Hengrui Pharmaceuticals Co can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Jiangsu Hengrui Pharmaceuticals Co affect the company?

A reduction in debt of Jiangsu Hengrui Pharmaceuticals Co can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Jiangsu Hengrui Pharmaceuticals Co?

Some factors that can influence the debt of Jiangsu Hengrui Pharmaceuticals Co include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Jiangsu Hengrui Pharmaceuticals Co so important for investors?

The debts of Jiangsu Hengrui Pharmaceuticals Co are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Jiangsu Hengrui Pharmaceuticals Co take to change the debt?

To change the debt, Jiangsu Hengrui Pharmaceuticals Co can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Jiangsu Hengrui Pharmaceuticals Co pay?

Over the past 12 months, Jiangsu Hengrui Pharmaceuticals Co paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Jiangsu Hengrui Pharmaceuticals Co is expected to pay a dividend of 0.17 CNY.

What is the dividend yield of Jiangsu Hengrui Pharmaceuticals Co?

The current dividend yield of Jiangsu Hengrui Pharmaceuticals Co is .

When does Jiangsu Hengrui Pharmaceuticals Co pay dividends?

Jiangsu Hengrui Pharmaceuticals Co pays a quarterly dividend. This is distributed in the months of June, July, August, July.

How secure is the dividend of Jiangsu Hengrui Pharmaceuticals Co?

Jiangsu Hengrui Pharmaceuticals Co paid dividends every year for the past 0 years.

What is the dividend of Jiangsu Hengrui Pharmaceuticals Co?

For the upcoming 12 months, dividends amounting to 0.17 CNY are expected. This corresponds to a dividend yield of 0.44 %.

In which sector is Jiangsu Hengrui Pharmaceuticals Co located?

Jiangsu Hengrui Pharmaceuticals Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Jiangsu Hengrui Pharmaceuticals Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Jiangsu Hengrui Pharmaceuticals Co from 6/8/2023 amounting to 0.16 CNY, you needed to have the stock in your portfolio before the ex-date on 6/8/2023.

When did Jiangsu Hengrui Pharmaceuticals Co pay the last dividend?

The last dividend was paid out on 6/8/2023.

What was the dividend of Jiangsu Hengrui Pharmaceuticals Co in the year 2023?

In the year 2023, Jiangsu Hengrui Pharmaceuticals Co distributed 0.16 CNY as dividends.

In which currency does Jiangsu Hengrui Pharmaceuticals Co pay out the dividend?

The dividends of Jiangsu Hengrui Pharmaceuticals Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Jiangsu Hengrui Pharmaceuticals Co

Our stock analysis for Jiangsu Hengrui Pharmaceuticals Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Jiangsu Hengrui Pharmaceuticals Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.